Elaine Ku1, Eric Vittinghoff2, David R Jacobs3, Cora E Lewis4, Norrina B Allen5, Kirsten Bibbins-Domingo6, Michael Shlipak7, Holly Kramer8, Carmen A Peralta9. 1. Division of Nephrology, Department of Medicine, University of California, San Francisco, CA; Division of Pediatric Nephrology, Department of Pediatrics, University of California, San Francisco, CA. Electronic address: elaine.ku@ucsf.edu. 2. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA. 3. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, MN. 4. Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL. 5. Department of Preventive Medicine and Medicine, Northwestern University, Chicago, IL. 6. Division of General Internal Medicine, Departments of Medicine and Epidemiology and Biostatistics, San Francisco General Hospital, San Francisco, CA. 7. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA; Division of General Internal Medicine, San Francisco Veterans Affair Medical Center, San Francisco, CA; and Department of Medicine and Kidney Health Research Collaborative. 8. Division of Nephrology, Department of Medicine, Loyola Medicine, Chicago, IL. 9. Division of Nephrology, Department of Medicine, University of California, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA; Division of General Internal Medicine, San Francisco Veterans Affair Medical Center, San Francisco, CA; and Department of Medicine and Kidney Health Research Collaborative.
Abstract
BACKGROUND: Many studies have focused on the association between a single blood pressure (BP) measurement and risk for adverse outcomes. However, the association of BP trajectories during young adulthood with subsequent decline in kidney function has not been well defined. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: 3,429 participants in the Coronary Artery Risk Development in Young Adulthood (CARDIA) Study enrolled between the ages of 18 and 30 years. PREDICTORS: BP slope during the first 10 years of participation in CARDIA, derived from linear mixed models incorporating all repeated BP measures. OUTCOME: Decline in estimated glomerular filtration rate (eGFR) during the interval between years 10 and 20 of CARDIA participation using cystatin C measured at years 10, 15, and 20. RESULTS: Mean age of CARDIA participants at year 0 was 25.1 years, 56% were women, and 53% were white. Every 10-mmHg higher level of systolic (SBP) and diastolic BP (DBP) in year 10 was associated with change in eGFR of -0.09 (95% CI, -0.13 to -0.06) and -0.07 (95% CI, -0.12 to -0.03) mL/min/1.73m2 per year, respectively. Every 10-mmHg increase in SBP slope between years 0 and 10 was associated with a subsequent -0.52 (95% CI, -1.02 to -0.03) mL/min/1.73m2 per year change in kidney function after adjustment for comorbid conditions and SBP at year 10. Similarly, every 10-mmHg increase in DBP slope between years 0 and 10 was associated with a subsequent change in kidney function of -0.65 (95% CI, -1.23 to -0.07) mL/min/1.73m2 per year, after adjustment for comorbid conditions and DBP in year 10. LIMITATIONS: Observational design. CONCLUSIONS: During young adulthood, increasing SBP and DBP are associated with a higher rate of subsequent kidney function decline, independent of BP measured at the beginning of eGFR assessment.
BACKGROUND: Many studies have focused on the association between a single blood pressure (BP) measurement and risk for adverse outcomes. However, the association of BP trajectories during young adulthood with subsequent decline in kidney function has not been well defined. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: 3,429 participants in the Coronary Artery Risk Development in Young Adulthood (CARDIA) Study enrolled between the ages of 18 and 30 years. PREDICTORS: BP slope during the first 10 years of participation in CARDIA, derived from linear mixed models incorporating all repeated BP measures. OUTCOME: Decline in estimated glomerular filtration rate (eGFR) during the interval between years 10 and 20 of CARDIA participation using cystatin C measured at years 10, 15, and 20. RESULTS: Mean age of CARDIA participants at year 0 was 25.1 years, 56% were women, and 53% were white. Every 10-mmHg higher level of systolic (SBP) and diastolic BP (DBP) in year 10 was associated with change in eGFR of -0.09 (95% CI, -0.13 to -0.06) and -0.07 (95% CI, -0.12 to -0.03) mL/min/1.73m2 per year, respectively. Every 10-mmHg increase in SBP slope between years 0 and 10 was associated with a subsequent -0.52 (95% CI, -1.02 to -0.03) mL/min/1.73m2 per year change in kidney function after adjustment for comorbid conditions and SBP at year 10. Similarly, every 10-mmHg increase in DBP slope between years 0 and 10 was associated with a subsequent change in kidney function of -0.65 (95% CI, -1.23 to -0.07) mL/min/1.73m2 per year, after adjustment for comorbid conditions and DBP in year 10. LIMITATIONS: Observational design. CONCLUSIONS: During young adulthood, increasing SBP and DBP are associated with a higher rate of subsequent kidney function decline, independent of BP measured at the beginning of eGFR assessment.
Authors: Yuichiro Yano; Jared P Reis; Yacob G Tedla; David C Goff; David R Jacobs; Stephen Sidney; Hongyan Ning; Kiang Liu; Philip Greenland; Donald M Lloyd-Jones Journal: JAMA Cardiol Date: 2017-04-01 Impact factor: 14.676
Authors: Areef Ishani; Greg A Grandits; Richard H Grimm; Kenneth H Svendsen; Allan J Collins; Ronald J Prineas; James D Neaton Journal: J Am Soc Nephrol Date: 2006-04-12 Impact factor: 10.121
Authors: Ronald M A Henry; Piet J Kostense; Griët Bos; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Lex M Bouter; Coen D A Stehouwer Journal: Kidney Int Date: 2002-10 Impact factor: 10.612
Authors: Nynke Halbesma; Auke H Brantsma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E De Jong; Ronald T Gansevoort Journal: Kidney Int Date: 2008-05-21 Impact factor: 10.612
Authors: Olli T Raitakari; Markus Juonala; Mika Kähönen; Leena Taittonen; Tomi Laitinen; Noora Mäki-Torkko; Mikko J Järvisalo; Matti Uhari; Eero Jokinen; Tapani Rönnemaa; Hans K Akerblom; Jorma S A Viikari Journal: JAMA Date: 2003-11-05 Impact factor: 56.272
Authors: M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler Journal: N Engl J Med Date: 1996-01-04 Impact factor: 91.245